HMEU:LSE:LSE-HSBC MSCI Europe UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 1519.8

Change

+7.90 (+0.52)%

Market Cap

USD 0.19B

Volume

2.65K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-01 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+1.69 (+0.60%)

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

+1.48 (+2.19%)

USD 292,109.19B
0R1O:LSE Amazon.com Inc.

+0.75 (+0.38%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+3.80 (+3.12%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.16 (+0.89%)

USD 608.02B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.03 (+0.23%)

USD 608.02B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

+11.00 (+0.54%)

USD 321.87B
0QZK:LSE Coca-Cola Co.

+0.30 (+0.48%)

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing HMEU:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.25% 59% D- 61% D-
Dividend Return 0.01% 18% F 14% F
Total Return 6.26% 59% D- 61% D-
Trailing 12 Months  
Capital Gain 9.99% 55% F 59% D-
Dividend Return 0.03% 28% F 30% F
Total Return 10.02% 53% F 58% F
Trailing 5 Years  
Capital Gain 23.67% 50% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.67% 47% F 58% F
Average Annual (5 Year Horizon)  
Capital Gain 6.26% 58% F 62% D
Dividend Return 6.27% 58% F 62% D
Total Return 0.01% 18% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 10.39% 64% D 78% C+
Risk Adjusted Return 60.30% 72% C 82% B
Market Capitalization 0.19B 55% F 40% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.